Global Karyotyping Service Supply, Demand and Key Producers, 2026-2032
The global Karyotyping Service market size is expected to reach $ 1166 million by 2032, rising at a market growth of 6.0% CAGR during the forecast period (2026-2032).
Karyotyping Service refers to professional cytogenetic testing services that analyze the number, structure, and morphology of chromosomes through laboratory-based chromosome preparation, staining, imaging, and interpretation processes. The service focuses on identifying chromosomal abnormalities, numerical variations, structural rearrangements, and genetic characteristics from biological samples such as peripheral blood, amniotic fluid, bone marrow, tumor tissue, and cultured cells. Core technologies include conventional chromosome analysis, G-banding, high-resolution karyotyping, and related chromosome visualization techniques. Karyotyping Service is widely applied in clinical diagnosis, prenatal testing, reproductive health evaluation, oncology cytogenetics, genetic disease research, and cell line characterization.
This report is a detailed and comprehensive analysis of the world market for Karyotyping Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Karyotyping Service that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Karyotyping Service market
2. What is the demand of the global Karyotyping Service market?
3. What is the year over year growth of the global Karyotyping Service market?
4. What is the total value of the global Karyotyping Service market?
5. Who are the Major Players in the global Karyotyping Service market?
6. What are the growth factors driving the market demand?
Karyotyping Service refers to professional cytogenetic testing services that analyze the number, structure, and morphology of chromosomes through laboratory-based chromosome preparation, staining, imaging, and interpretation processes. The service focuses on identifying chromosomal abnormalities, numerical variations, structural rearrangements, and genetic characteristics from biological samples such as peripheral blood, amniotic fluid, bone marrow, tumor tissue, and cultured cells. Core technologies include conventional chromosome analysis, G-banding, high-resolution karyotyping, and related chromosome visualization techniques. Karyotyping Service is widely applied in clinical diagnosis, prenatal testing, reproductive health evaluation, oncology cytogenetics, genetic disease research, and cell line characterization.
Key Findings
- Karyotyping Service is widely used in clinical diagnosis prenatal testing and cytogenetic research applications
- Clinical diagnostic laboratories and hospitals represent the core end-user groups for Karyotyping Service
- Peripheral blood and prenatal samples are major specimen types in routine chromosome analysis services
- G-banding remains the mainstream technology route for conventional Karyotyping Service
- North America and Europe maintain important positions in advanced cytogenetic testing services
Market Trends
The Karyotyping Service industry is evolving toward higher testing accuracy, improved automation, and integration with advanced genomic technologies. Traditional chromosome analysis methods continue to play an important role in clinical cytogenetics due to their ability to provide comprehensive chromosome-level information, while service providers are increasingly combining conventional karyotyping with complementary molecular techniques to improve diagnostic capability. The market is also moving toward faster turnaround times, digital chromosome imaging, automated analysis platforms, and customized testing solutions for clinical and research applications.Market Dynamics
Drivers
Growing demand for genetic disease diagnosis, prenatal screening, reproductive health assessment, and oncology cytogenetics is driving the expansion of Karyotyping Service applications. Increasing awareness of chromosomal abnormalities and the development of precision medicine are supporting broader adoption of cytogenetic testing services across healthcare systems.Restraints
The market is constrained by the complexity of chromosome preparation, requirement for experienced cytogenetic specialists, relatively long testing cycles compared with some molecular diagnostic methods, and dependence on laboratory quality control systems. Standardization across different laboratories also remains an important factor affecting service consistency.Opportunities
Increasing applications in personalized medicine, fertility management, rare disease diagnosis, and advanced biomedical research create new opportunities for Karyotyping Service providers. The integration of digital imaging, artificial intelligence-assisted chromosome analysis, and automated laboratory workflows is expected to improve service efficiency and expand application scenarios.Challenges
The industry faces challenges from competition with next-generation sequencing and molecular genetic testing technologies, reimbursement differences across regions, and the need to maintain high diagnostic accuracy. Service providers must continuously enhance technical capabilities, regulatory compliance, and laboratory infrastructure to remain competitive.Industry Chain Analysis
The Karyotyping Service industry chain includes upstream biological sample collection, laboratory reagents, chromosome preparation materials, imaging equipment, and analytical technologies; midstream professional testing laboratories provide sample processing, chromosome culture, staining, imaging, interpretation, and reporting services; downstream users include hospitals, diagnostic laboratories, fertility centers, biotechnology companies, pharmaceutical companies, and research institutions. Value creation mainly occurs through laboratory expertise, testing accuracy, turnaround efficiency, and clinical interpretation capability. Compared with standardized laboratory products, Karyotyping Service relies heavily on technical experience, quality management systems, and professional reporting capabilities.Segment Insights
Karyotyping Service can be segmented by service type, detection technology, sample type, application scenario, and end-user group. Conventional Karyotyping Service based on chromosome banding remains the largest segment because of its established clinical application foundation and ability to detect large chromosomal abnormalities. Prenatal testing and clinical diagnosis represent major application areas, while oncology cytogenetics and research applications provide additional growth opportunities. From the technology perspective, improvements in digital imaging, automated chromosome recognition, and integration with molecular cytogenetic methods are becoming important directions for service enhancement.Downstream Market Opportunities
The downstream opportunities for Karyotyping Service are mainly concentrated in hospitals, diagnostic laboratories, reproductive medicine centers, biotechnology companies, pharmaceutical research organizations, and academic institutions. Clinical diagnosis and prenatal testing remain the primary demand areas, supported by continued needs for chromosome abnormality detection and genetic risk assessment. Emerging opportunities are also developing in oncology research, cell line quality control, and biomedical innovation where chromosome analysis supports research validation and biological characterization.Regional Insights
North America and Europe represent important regional markets for Karyotyping Service due to their established healthcare infrastructure, mature genetic testing systems, and strong research capabilities. These regions have broad adoption in clinical cytogenetics, prenatal diagnosis, and biomedical research. Asia Pacific is becoming an important growth region driven by expanding healthcare services, increasing genetic testing demand, and development of biotechnology research capabilities. Regional market differences are mainly reflected in healthcare access, reimbursement systems, laboratory capacity, and regulatory environments.Competitive Landscape Analysis
The Karyotyping Service market has a diversified competitive structure consisting of clinical laboratories, specialized genetic testing providers, research service companies, and biotechnology service organizations. Competition is mainly focused on testing accuracy, laboratory accreditation, turnaround time, technical expertise, and ability to provide integrated genetic analysis solutions. Leading service providers typically strengthen their market position through advanced laboratory platforms, experienced cytogenetic teams, comprehensive quality systems, and broad customer coverage across clinical and research applications. The market does not show a single dominant model, with competition influenced by regional healthcare systems and specialized service capabilities.Report Scope
This report studies the global Karyotyping Service demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Karyotyping Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Karyotyping Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Karyotyping Service total market, 2021-2032, (USD Million)
- Global Karyotyping Service total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Karyotyping Service total market, key domestic companies, and share, (USD Million)
- Global Karyotyping Service revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Karyotyping Service total market by Type, CAGR, 2021-2032, (USD Million)
- Global Karyotyping Service total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Karyotyping Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Karyotyping Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Karyotyping Service Market, Segmentation by Type:
- G-Banding Karyotyping
- Q-Banding Karyotyping
- R-Banding Karyotyping
- C-Banding Karyotyping
- Spectral Karyotyping (SKY)
- Multicolor FISH-based Karyotyping
Global Karyotyping Service Market, Segmentation by Sample:
- Peripheral Blood Karyotyping
- Amniotic Fluid Karyotyping
- Chorionic Villus Sample Karyotyping
- Bone Marrow Karyotyping
- Tumor Tissue Karyotyping
- Cell Culture Karyotyping
Global Karyotyping Service Market, Segmentation by Resolution:
- Low Resolution Karyotype Analysis (350–450 bands)
- Medium Resolution Karyotype Analysis (450–550 bands)
- High Resolution Karyotype Analysis (550–850+ bands)
Global Karyotyping Service Market, Segmentation by Application:
- Hospitals and Medical Centers
- Diagnostic Laboratories
- Fertility Clinics
- Biotechnology Companies
- Pharmaceutical Companies
- Academic and Research Institutions
Companies Profiled:
- Labcorp
- Quest Diagnostics Incorporated
- Eurofins Scientific
- Charles River Laboratories
- Thermo Fisher Scientific
- Agilent Technologies
- Illumina
- Bionano Genomics
- Natera
- NeoGenomics Laboratories
- Invitae
- Fulgent Genetics
- BGI Genomics
- Berry Genomics
- KingMed Diagnostics
- Daan Gene
- Maccura Biotechnology
Key Questions Answered
1. How big is the global Karyotyping Service market?2. What is the demand of the global Karyotyping Service market?
3. What is the year over year growth of the global Karyotyping Service market?
4. What is the total value of the global Karyotyping Service market?
5. Who are the Major Players in the global Karyotyping Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Karyotyping Service Introduction
1.2 World Karyotyping Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Karyotyping Service Total Market by Region (by Headquarter Location)
1.3.1 World Karyotyping Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Karyotyping Service Revenue (2021-2032)
1.3.3 China Based Company Karyotyping Service Revenue (2021-2032)
1.3.4 Europe Based Company Karyotyping Service Revenue (2021-2032)
1.3.5 Japan Based Company Karyotyping Service Revenue (2021-2032)
1.3.6 South Korea Based Company Karyotyping Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Karyotyping Service Revenue (2021-2032)
1.3.8 India Based Company Karyotyping Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Karyotyping Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Karyotyping Service Consumption Value (2021-2032)
2.2 World Karyotyping Service Consumption Value by Region
2.2.1 World Karyotyping Service Consumption Value by Region (2021-2026)
2.2.2 World Karyotyping Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Karyotyping Service Consumption Value (2021-2032)
2.4 China Karyotyping Service Consumption Value (2021-2032)
2.5 Europe Karyotyping Service Consumption Value (2021-2032)
2.6 Japan Karyotyping Service Consumption Value (2021-2032)
2.7 South Korea Karyotyping Service Consumption Value (2021-2032)
2.8 ASEAN Karyotyping Service Consumption Value (2021-2032)
2.9 India Karyotyping Service Consumption Value (2021-2032)
3 WORLD KARYOTYPING SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Karyotyping Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Karyotyping Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Karyotyping Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Karyotyping Service in 2025
3.3 Karyotyping Service Company Evaluation Quadrant
3.4 Karyotyping Service Market: Overall Company Footprint Analysis
3.4.1 Karyotyping Service Market: Region Footprint
3.4.2 Karyotyping Service Market: Company Product Type Footprint
3.4.3 Karyotyping Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Karyotyping Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Karyotyping Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Karyotyping Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Karyotyping Service Consumption Value Comparison
4.2.1 United States VS China: Karyotyping Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Karyotyping Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Karyotyping Service Companies and Market Share, 2021-2026
4.3.1 United States Based Karyotyping Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Karyotyping Service Revenue, (2021-2026)
4.4 China Based Companies Karyotyping Service Revenue and Market Share, 2021-2026
4.4.1 China Based Karyotyping Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Karyotyping Service Revenue, (2021-2026)
4.5 Rest of World Based Karyotyping Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Karyotyping Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Karyotyping Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Karyotyping Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 G-Banding Karyotyping
5.2.2 Q-Banding Karyotyping
5.2.3 R-Banding Karyotyping
5.2.4 C-Banding Karyotyping
5.2.5 Spectral Karyotyping (SKY)
5.2.6 Multicolor FISH-based Karyotyping
5.3 Market Segment by Type
5.3.1 World Karyotyping Service Market Size by Type (2021-2026)
5.3.2 World Karyotyping Service Market Size by Type (2027-2032)
5.3.3 World Karyotyping Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SAMPLE
6.1 World Karyotyping Service Market Size Overview by Sample: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sample
6.2.1 Peripheral Blood Karyotyping
6.2.2 Amniotic Fluid Karyotyping
6.2.3 Chorionic Villus Sample Karyotyping
6.2.4 Bone Marrow Karyotyping
6.2.5 Tumor Tissue Karyotyping
6.2.6 Cell Culture Karyotyping
6.3 Market Segment by Sample
6.3.1 World Karyotyping Service Market Size by Sample (2021-2026)
6.3.2 World Karyotyping Service Market Size by Sample (2027-2032)
6.3.3 World Karyotyping Service Market Size Market Share by Sample (2027-2032)
7 MARKET ANALYSIS BY RESOLUTION
7.1 World Karyotyping Service Market Size Overview by Resolution: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Resolution
7.2.1 Low Resolution Karyotype Analysis (350–450 bands)
7.2.2 Medium Resolution Karyotype Analysis (450–550 bands)
7.2.3 High Resolution Karyotype Analysis (550–850+ bands)
7.3 Market Segment by Resolution
7.3.1 World Karyotyping Service Market Size by Resolution (2021-2026)
7.3.2 World Karyotyping Service Market Size by Resolution (2027-2032)
7.3.3 World Karyotyping Service Market Size Market Share by Resolution (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Karyotyping Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals and Medical Centers
8.2.2 Diagnostic Laboratories
8.2.3 Fertility Clinics
8.2.4 Biotechnology Companies
8.2.5 Pharmaceutical Companies
8.2.6 Academic and Research Institutions
8.3 Market Segment by Application
8.3.1 World Karyotyping Service Market Size by Application (2021-2026)
8.3.2 World Karyotyping Service Market Size by Application (2027-2032)
8.3.3 World Karyotyping Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Labcorp
9.1.1 Labcorp Details
9.1.2 Labcorp Major Business
9.1.3 Labcorp Karyotyping Service Product and Services
9.1.4 Labcorp Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Labcorp Recent Developments/Updates
9.1.6 Labcorp Competitive Strengths & Weaknesses
9.2 Quest Diagnostics Incorporated
9.2.1 Quest Diagnostics Incorporated Details
9.2.2 Quest Diagnostics Incorporated Major Business
9.2.3 Quest Diagnostics Incorporated Karyotyping Service Product and Services
9.2.4 Quest Diagnostics Incorporated Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Quest Diagnostics Incorporated Recent Developments/Updates
9.2.6 Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
9.3 Eurofins Scientific
9.3.1 Eurofins Scientific Details
9.3.2 Eurofins Scientific Major Business
9.3.3 Eurofins Scientific Karyotyping Service Product and Services
9.3.4 Eurofins Scientific Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Eurofins Scientific Recent Developments/Updates
9.3.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.4 Charles River Laboratories
9.4.1 Charles River Laboratories Details
9.4.2 Charles River Laboratories Major Business
9.4.3 Charles River Laboratories Karyotyping Service Product and Services
9.4.4 Charles River Laboratories Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Charles River Laboratories Recent Developments/Updates
9.4.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Details
9.5.2 Thermo Fisher Scientific Major Business
9.5.3 Thermo Fisher Scientific Karyotyping Service Product and Services
9.5.4 Thermo Fisher Scientific Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Thermo Fisher Scientific Recent Developments/Updates
9.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.6 Agilent Technologies
9.6.1 Agilent Technologies Details
9.6.2 Agilent Technologies Major Business
9.6.3 Agilent Technologies Karyotyping Service Product and Services
9.6.4 Agilent Technologies Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Agilent Technologies Recent Developments/Updates
9.6.6 Agilent Technologies Competitive Strengths & Weaknesses
9.7 Illumina
9.7.1 Illumina Details
9.7.2 Illumina Major Business
9.7.3 Illumina Karyotyping Service Product and Services
9.7.4 Illumina Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Illumina Recent Developments/Updates
9.7.6 Illumina Competitive Strengths & Weaknesses
9.8 Bionano Genomics
9.8.1 Bionano Genomics Details
9.8.2 Bionano Genomics Major Business
9.8.3 Bionano Genomics Karyotyping Service Product and Services
9.8.4 Bionano Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Bionano Genomics Recent Developments/Updates
9.8.6 Bionano Genomics Competitive Strengths & Weaknesses
9.9 Natera
9.9.1 Natera Details
9.9.2 Natera Major Business
9.9.3 Natera Karyotyping Service Product and Services
9.9.4 Natera Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Natera Recent Developments/Updates
9.9.6 Natera Competitive Strengths & Weaknesses
9.10 NeoGenomics Laboratories
9.10.1 NeoGenomics Laboratories Details
9.10.2 NeoGenomics Laboratories Major Business
9.10.3 NeoGenomics Laboratories Karyotyping Service Product and Services
9.10.4 NeoGenomics Laboratories Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 NeoGenomics Laboratories Recent Developments/Updates
9.10.6 NeoGenomics Laboratories Competitive Strengths & Weaknesses
9.11 Invitae
9.11.1 Invitae Details
9.11.2 Invitae Major Business
9.11.3 Invitae Karyotyping Service Product and Services
9.11.4 Invitae Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Invitae Recent Developments/Updates
9.11.6 Invitae Competitive Strengths & Weaknesses
9.12 Fulgent Genetics
9.12.1 Fulgent Genetics Details
9.12.2 Fulgent Genetics Major Business
9.12.3 Fulgent Genetics Karyotyping Service Product and Services
9.12.4 Fulgent Genetics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Fulgent Genetics Recent Developments/Updates
9.12.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.13 BGI Genomics
9.13.1 BGI Genomics Details
9.13.2 BGI Genomics Major Business
9.13.3 BGI Genomics Karyotyping Service Product and Services
9.13.4 BGI Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 BGI Genomics Recent Developments/Updates
9.13.6 BGI Genomics Competitive Strengths & Weaknesses
9.14 Berry Genomics
9.14.1 Berry Genomics Details
9.14.2 Berry Genomics Major Business
9.14.3 Berry Genomics Karyotyping Service Product and Services
9.14.4 Berry Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Berry Genomics Recent Developments/Updates
9.14.6 Berry Genomics Competitive Strengths & Weaknesses
9.15 KingMed Diagnostics
9.15.1 KingMed Diagnostics Details
9.15.2 KingMed Diagnostics Major Business
9.15.3 KingMed Diagnostics Karyotyping Service Product and Services
9.15.4 KingMed Diagnostics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 KingMed Diagnostics Recent Developments/Updates
9.15.6 KingMed Diagnostics Competitive Strengths & Weaknesses
9.16 Daan Gene
9.16.1 Daan Gene Details
9.16.2 Daan Gene Major Business
9.16.3 Daan Gene Karyotyping Service Product and Services
9.16.4 Daan Gene Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Daan Gene Recent Developments/Updates
9.16.6 Daan Gene Competitive Strengths & Weaknesses
9.17 Maccura Biotechnology
9.17.1 Maccura Biotechnology Details
9.17.2 Maccura Biotechnology Major Business
9.17.3 Maccura Biotechnology Karyotyping Service Product and Services
9.17.4 Maccura Biotechnology Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Maccura Biotechnology Recent Developments/Updates
9.17.6 Maccura Biotechnology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Karyotyping Service Industry Chain
10.2 Karyotyping Service Upstream Analysis
10.3 Karyotyping Service Midstream Analysis
10.4 Karyotyping Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Karyotyping Service Introduction
1.2 World Karyotyping Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Karyotyping Service Total Market by Region (by Headquarter Location)
1.3.1 World Karyotyping Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Karyotyping Service Revenue (2021-2032)
1.3.3 China Based Company Karyotyping Service Revenue (2021-2032)
1.3.4 Europe Based Company Karyotyping Service Revenue (2021-2032)
1.3.5 Japan Based Company Karyotyping Service Revenue (2021-2032)
1.3.6 South Korea Based Company Karyotyping Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Karyotyping Service Revenue (2021-2032)
1.3.8 India Based Company Karyotyping Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Karyotyping Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Karyotyping Service Consumption Value (2021-2032)
2.2 World Karyotyping Service Consumption Value by Region
2.2.1 World Karyotyping Service Consumption Value by Region (2021-2026)
2.2.2 World Karyotyping Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Karyotyping Service Consumption Value (2021-2032)
2.4 China Karyotyping Service Consumption Value (2021-2032)
2.5 Europe Karyotyping Service Consumption Value (2021-2032)
2.6 Japan Karyotyping Service Consumption Value (2021-2032)
2.7 South Korea Karyotyping Service Consumption Value (2021-2032)
2.8 ASEAN Karyotyping Service Consumption Value (2021-2032)
2.9 India Karyotyping Service Consumption Value (2021-2032)
3 WORLD KARYOTYPING SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Karyotyping Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Karyotyping Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Karyotyping Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Karyotyping Service in 2025
3.3 Karyotyping Service Company Evaluation Quadrant
3.4 Karyotyping Service Market: Overall Company Footprint Analysis
3.4.1 Karyotyping Service Market: Region Footprint
3.4.2 Karyotyping Service Market: Company Product Type Footprint
3.4.3 Karyotyping Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Karyotyping Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Karyotyping Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Karyotyping Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Karyotyping Service Consumption Value Comparison
4.2.1 United States VS China: Karyotyping Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Karyotyping Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Karyotyping Service Companies and Market Share, 2021-2026
4.3.1 United States Based Karyotyping Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Karyotyping Service Revenue, (2021-2026)
4.4 China Based Companies Karyotyping Service Revenue and Market Share, 2021-2026
4.4.1 China Based Karyotyping Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Karyotyping Service Revenue, (2021-2026)
4.5 Rest of World Based Karyotyping Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Karyotyping Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Karyotyping Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Karyotyping Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 G-Banding Karyotyping
5.2.2 Q-Banding Karyotyping
5.2.3 R-Banding Karyotyping
5.2.4 C-Banding Karyotyping
5.2.5 Spectral Karyotyping (SKY)
5.2.6 Multicolor FISH-based Karyotyping
5.3 Market Segment by Type
5.3.1 World Karyotyping Service Market Size by Type (2021-2026)
5.3.2 World Karyotyping Service Market Size by Type (2027-2032)
5.3.3 World Karyotyping Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SAMPLE
6.1 World Karyotyping Service Market Size Overview by Sample: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sample
6.2.1 Peripheral Blood Karyotyping
6.2.2 Amniotic Fluid Karyotyping
6.2.3 Chorionic Villus Sample Karyotyping
6.2.4 Bone Marrow Karyotyping
6.2.5 Tumor Tissue Karyotyping
6.2.6 Cell Culture Karyotyping
6.3 Market Segment by Sample
6.3.1 World Karyotyping Service Market Size by Sample (2021-2026)
6.3.2 World Karyotyping Service Market Size by Sample (2027-2032)
6.3.3 World Karyotyping Service Market Size Market Share by Sample (2027-2032)
7 MARKET ANALYSIS BY RESOLUTION
7.1 World Karyotyping Service Market Size Overview by Resolution: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Resolution
7.2.1 Low Resolution Karyotype Analysis (350–450 bands)
7.2.2 Medium Resolution Karyotype Analysis (450–550 bands)
7.2.3 High Resolution Karyotype Analysis (550–850+ bands)
7.3 Market Segment by Resolution
7.3.1 World Karyotyping Service Market Size by Resolution (2021-2026)
7.3.2 World Karyotyping Service Market Size by Resolution (2027-2032)
7.3.3 World Karyotyping Service Market Size Market Share by Resolution (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Karyotyping Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals and Medical Centers
8.2.2 Diagnostic Laboratories
8.2.3 Fertility Clinics
8.2.4 Biotechnology Companies
8.2.5 Pharmaceutical Companies
8.2.6 Academic and Research Institutions
8.3 Market Segment by Application
8.3.1 World Karyotyping Service Market Size by Application (2021-2026)
8.3.2 World Karyotyping Service Market Size by Application (2027-2032)
8.3.3 World Karyotyping Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Labcorp
9.1.1 Labcorp Details
9.1.2 Labcorp Major Business
9.1.3 Labcorp Karyotyping Service Product and Services
9.1.4 Labcorp Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Labcorp Recent Developments/Updates
9.1.6 Labcorp Competitive Strengths & Weaknesses
9.2 Quest Diagnostics Incorporated
9.2.1 Quest Diagnostics Incorporated Details
9.2.2 Quest Diagnostics Incorporated Major Business
9.2.3 Quest Diagnostics Incorporated Karyotyping Service Product and Services
9.2.4 Quest Diagnostics Incorporated Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Quest Diagnostics Incorporated Recent Developments/Updates
9.2.6 Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
9.3 Eurofins Scientific
9.3.1 Eurofins Scientific Details
9.3.2 Eurofins Scientific Major Business
9.3.3 Eurofins Scientific Karyotyping Service Product and Services
9.3.4 Eurofins Scientific Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Eurofins Scientific Recent Developments/Updates
9.3.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.4 Charles River Laboratories
9.4.1 Charles River Laboratories Details
9.4.2 Charles River Laboratories Major Business
9.4.3 Charles River Laboratories Karyotyping Service Product and Services
9.4.4 Charles River Laboratories Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Charles River Laboratories Recent Developments/Updates
9.4.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Details
9.5.2 Thermo Fisher Scientific Major Business
9.5.3 Thermo Fisher Scientific Karyotyping Service Product and Services
9.5.4 Thermo Fisher Scientific Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Thermo Fisher Scientific Recent Developments/Updates
9.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.6 Agilent Technologies
9.6.1 Agilent Technologies Details
9.6.2 Agilent Technologies Major Business
9.6.3 Agilent Technologies Karyotyping Service Product and Services
9.6.4 Agilent Technologies Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Agilent Technologies Recent Developments/Updates
9.6.6 Agilent Technologies Competitive Strengths & Weaknesses
9.7 Illumina
9.7.1 Illumina Details
9.7.2 Illumina Major Business
9.7.3 Illumina Karyotyping Service Product and Services
9.7.4 Illumina Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Illumina Recent Developments/Updates
9.7.6 Illumina Competitive Strengths & Weaknesses
9.8 Bionano Genomics
9.8.1 Bionano Genomics Details
9.8.2 Bionano Genomics Major Business
9.8.3 Bionano Genomics Karyotyping Service Product and Services
9.8.4 Bionano Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Bionano Genomics Recent Developments/Updates
9.8.6 Bionano Genomics Competitive Strengths & Weaknesses
9.9 Natera
9.9.1 Natera Details
9.9.2 Natera Major Business
9.9.3 Natera Karyotyping Service Product and Services
9.9.4 Natera Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Natera Recent Developments/Updates
9.9.6 Natera Competitive Strengths & Weaknesses
9.10 NeoGenomics Laboratories
9.10.1 NeoGenomics Laboratories Details
9.10.2 NeoGenomics Laboratories Major Business
9.10.3 NeoGenomics Laboratories Karyotyping Service Product and Services
9.10.4 NeoGenomics Laboratories Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 NeoGenomics Laboratories Recent Developments/Updates
9.10.6 NeoGenomics Laboratories Competitive Strengths & Weaknesses
9.11 Invitae
9.11.1 Invitae Details
9.11.2 Invitae Major Business
9.11.3 Invitae Karyotyping Service Product and Services
9.11.4 Invitae Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Invitae Recent Developments/Updates
9.11.6 Invitae Competitive Strengths & Weaknesses
9.12 Fulgent Genetics
9.12.1 Fulgent Genetics Details
9.12.2 Fulgent Genetics Major Business
9.12.3 Fulgent Genetics Karyotyping Service Product and Services
9.12.4 Fulgent Genetics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Fulgent Genetics Recent Developments/Updates
9.12.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.13 BGI Genomics
9.13.1 BGI Genomics Details
9.13.2 BGI Genomics Major Business
9.13.3 BGI Genomics Karyotyping Service Product and Services
9.13.4 BGI Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 BGI Genomics Recent Developments/Updates
9.13.6 BGI Genomics Competitive Strengths & Weaknesses
9.14 Berry Genomics
9.14.1 Berry Genomics Details
9.14.2 Berry Genomics Major Business
9.14.3 Berry Genomics Karyotyping Service Product and Services
9.14.4 Berry Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Berry Genomics Recent Developments/Updates
9.14.6 Berry Genomics Competitive Strengths & Weaknesses
9.15 KingMed Diagnostics
9.15.1 KingMed Diagnostics Details
9.15.2 KingMed Diagnostics Major Business
9.15.3 KingMed Diagnostics Karyotyping Service Product and Services
9.15.4 KingMed Diagnostics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 KingMed Diagnostics Recent Developments/Updates
9.15.6 KingMed Diagnostics Competitive Strengths & Weaknesses
9.16 Daan Gene
9.16.1 Daan Gene Details
9.16.2 Daan Gene Major Business
9.16.3 Daan Gene Karyotyping Service Product and Services
9.16.4 Daan Gene Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Daan Gene Recent Developments/Updates
9.16.6 Daan Gene Competitive Strengths & Weaknesses
9.17 Maccura Biotechnology
9.17.1 Maccura Biotechnology Details
9.17.2 Maccura Biotechnology Major Business
9.17.3 Maccura Biotechnology Karyotyping Service Product and Services
9.17.4 Maccura Biotechnology Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Maccura Biotechnology Recent Developments/Updates
9.17.6 Maccura Biotechnology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Karyotyping Service Industry Chain
10.2 Karyotyping Service Upstream Analysis
10.3 Karyotyping Service Midstream Analysis
10.4 Karyotyping Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Karyotyping Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Karyotyping Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Karyotyping Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Karyotyping Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Karyotyping Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Karyotyping Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Karyotyping Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Karyotyping Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Karyotyping Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Karyotyping Service Players in 2025
Table 12. World Karyotyping Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Karyotyping Service Company Evaluation Quadrant
Table 14. Head Office of Key Karyotyping Service Players
Table 15. Karyotyping Service Market: Company Product Type Footprint
Table 16. Karyotyping Service Market: Company Product Application Footprint
Table 17. Karyotyping Service Mergers & Acquisitions Activity
Table 18. United States VS China Karyotyping Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Karyotyping Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Karyotyping Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Karyotyping Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Karyotyping Service Revenue Market Share (2021-2026)
Table 23. China Based Karyotyping Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Karyotyping Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Karyotyping Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Karyotyping Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Karyotyping Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Karyotyping Service Revenue Market Share (2021-2026)
Table 29. World Karyotyping Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Karyotyping Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Karyotyping Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Karyotyping Service Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Table 33. World Karyotyping Service Market Size Value by Sample (2021-2026) & (USD Million)
Table 34. World Karyotyping Service Market Size by Sample (2027-2032) & (USD Million)
Table 35. World Karyotyping Service Market Size by Resolution, (USD Million), 2021 & 2025 & 2032
Table 36. World Karyotyping Service Market Size Value by Resolution (2021-2026) & (USD Million)
Table 37. World Karyotyping Service Market Size by Resolution (2027-2032) & (USD Million)
Table 38. World Karyotyping Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Karyotyping Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Karyotyping Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Labcorp Basic Information, Manufacturing Base and Competitors
Table 42. Labcorp Major Business
Table 43. Labcorp Karyotyping Service Product and Services
Table 44. Labcorp Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Labcorp Recent Developments/Updates
Table 46. Labcorp Competitive Strengths & Weaknesses
Table 47. Quest Diagnostics Incorporated Basic Information, Manufacturing Base and Competitors
Table 48. Quest Diagnostics Incorporated Major Business
Table 49. Quest Diagnostics Incorporated Karyotyping Service Product and Services
Table 50. Quest Diagnostics Incorporated Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Quest Diagnostics Incorporated Recent Developments/Updates
Table 52. Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
Table 53. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Eurofins Scientific Major Business
Table 55. Eurofins Scientific Karyotyping Service Product and Services
Table 56. Eurofins Scientific Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Eurofins Scientific Recent Developments/Updates
Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
Table 59. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Charles River Laboratories Major Business
Table 61. Charles River Laboratories Karyotyping Service Product and Services
Table 62. Charles River Laboratories Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Charles River Laboratories Recent Developments/Updates
Table 64. Charles River Laboratories Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 66. Thermo Fisher Scientific Major Business
Table 67. Thermo Fisher Scientific Karyotyping Service Product and Services
Table 68. Thermo Fisher Scientific Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Thermo Fisher Scientific Recent Developments/Updates
Table 70. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 71. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 72. Agilent Technologies Major Business
Table 73. Agilent Technologies Karyotyping Service Product and Services
Table 74. Agilent Technologies Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Agilent Technologies Recent Developments/Updates
Table 76. Agilent Technologies Competitive Strengths & Weaknesses
Table 77. Illumina Basic Information, Manufacturing Base and Competitors
Table 78. Illumina Major Business
Table 79. Illumina Karyotyping Service Product and Services
Table 80. Illumina Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Illumina Recent Developments/Updates
Table 82. Illumina Competitive Strengths & Weaknesses
Table 83. Bionano Genomics Basic Information, Manufacturing Base and Competitors
Table 84. Bionano Genomics Major Business
Table 85. Bionano Genomics Karyotyping Service Product and Services
Table 86. Bionano Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Bionano Genomics Recent Developments/Updates
Table 88. Bionano Genomics Competitive Strengths & Weaknesses
Table 89. Natera Basic Information, Manufacturing Base and Competitors
Table 90. Natera Major Business
Table 91. Natera Karyotyping Service Product and Services
Table 92. Natera Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Natera Recent Developments/Updates
Table 94. Natera Competitive Strengths & Weaknesses
Table 95. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 96. NeoGenomics Laboratories Major Business
Table 97. NeoGenomics Laboratories Karyotyping Service Product and Services
Table 98. NeoGenomics Laboratories Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. NeoGenomics Laboratories Recent Developments/Updates
Table 100. NeoGenomics Laboratories Competitive Strengths & Weaknesses
Table 101. Invitae Basic Information, Manufacturing Base and Competitors
Table 102. Invitae Major Business
Table 103. Invitae Karyotyping Service Product and Services
Table 104. Invitae Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Invitae Recent Developments/Updates
Table 106. Invitae Competitive Strengths & Weaknesses
Table 107. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 108. Fulgent Genetics Major Business
Table 109. Fulgent Genetics Karyotyping Service Product and Services
Table 110. Fulgent Genetics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Fulgent Genetics Recent Developments/Updates
Table 112. Fulgent Genetics Competitive Strengths & Weaknesses
Table 113. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 114. BGI Genomics Major Business
Table 115. BGI Genomics Karyotyping Service Product and Services
Table 116. BGI Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BGI Genomics Recent Developments/Updates
Table 118. BGI Genomics Competitive Strengths & Weaknesses
Table 119. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Berry Genomics Major Business
Table 121. Berry Genomics Karyotyping Service Product and Services
Table 122. Berry Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Berry Genomics Recent Developments/Updates
Table 124. Berry Genomics Competitive Strengths & Weaknesses
Table 125. KingMed Diagnostics Basic Information, Manufacturing Base and Competitors
Table 126. KingMed Diagnostics Major Business
Table 127. KingMed Diagnostics Karyotyping Service Product and Services
Table 128. KingMed Diagnostics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. KingMed Diagnostics Recent Developments/Updates
Table 130. KingMed Diagnostics Competitive Strengths & Weaknesses
Table 131. Daan Gene Basic Information, Manufacturing Base and Competitors
Table 132. Daan Gene Major Business
Table 133. Daan Gene Karyotyping Service Product and Services
Table 134. Daan Gene Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Daan Gene Recent Developments/Updates
Table 136. Daan Gene Competitive Strengths & Weaknesses
Table 137. Maccura Biotechnology Basic Information, Manufacturing Base and Competitors
Table 138. Maccura Biotechnology Major Business
Table 139. Maccura Biotechnology Karyotyping Service Product and Services
Table 140. Maccura Biotechnology Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Maccura Biotechnology Recent Developments/Updates
Table 142. Maccura Biotechnology Competitive Strengths & Weaknesses
Table 143. Global Key Players of Karyotyping Service Upstream (Raw Materials)
Table 144. Global Karyotyping Service Typical Customers
Table 1. World Karyotyping Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Karyotyping Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Karyotyping Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Karyotyping Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Karyotyping Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Karyotyping Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Karyotyping Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Karyotyping Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Karyotyping Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Karyotyping Service Players in 2025
Table 12. World Karyotyping Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Karyotyping Service Company Evaluation Quadrant
Table 14. Head Office of Key Karyotyping Service Players
Table 15. Karyotyping Service Market: Company Product Type Footprint
Table 16. Karyotyping Service Market: Company Product Application Footprint
Table 17. Karyotyping Service Mergers & Acquisitions Activity
Table 18. United States VS China Karyotyping Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Karyotyping Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Karyotyping Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Karyotyping Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Karyotyping Service Revenue Market Share (2021-2026)
Table 23. China Based Karyotyping Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Karyotyping Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Karyotyping Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Karyotyping Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Karyotyping Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Karyotyping Service Revenue Market Share (2021-2026)
Table 29. World Karyotyping Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Karyotyping Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Karyotyping Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Karyotyping Service Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Table 33. World Karyotyping Service Market Size Value by Sample (2021-2026) & (USD Million)
Table 34. World Karyotyping Service Market Size by Sample (2027-2032) & (USD Million)
Table 35. World Karyotyping Service Market Size by Resolution, (USD Million), 2021 & 2025 & 2032
Table 36. World Karyotyping Service Market Size Value by Resolution (2021-2026) & (USD Million)
Table 37. World Karyotyping Service Market Size by Resolution (2027-2032) & (USD Million)
Table 38. World Karyotyping Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Karyotyping Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Karyotyping Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Labcorp Basic Information, Manufacturing Base and Competitors
Table 42. Labcorp Major Business
Table 43. Labcorp Karyotyping Service Product and Services
Table 44. Labcorp Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Labcorp Recent Developments/Updates
Table 46. Labcorp Competitive Strengths & Weaknesses
Table 47. Quest Diagnostics Incorporated Basic Information, Manufacturing Base and Competitors
Table 48. Quest Diagnostics Incorporated Major Business
Table 49. Quest Diagnostics Incorporated Karyotyping Service Product and Services
Table 50. Quest Diagnostics Incorporated Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Quest Diagnostics Incorporated Recent Developments/Updates
Table 52. Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
Table 53. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Eurofins Scientific Major Business
Table 55. Eurofins Scientific Karyotyping Service Product and Services
Table 56. Eurofins Scientific Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Eurofins Scientific Recent Developments/Updates
Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
Table 59. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Charles River Laboratories Major Business
Table 61. Charles River Laboratories Karyotyping Service Product and Services
Table 62. Charles River Laboratories Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Charles River Laboratories Recent Developments/Updates
Table 64. Charles River Laboratories Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 66. Thermo Fisher Scientific Major Business
Table 67. Thermo Fisher Scientific Karyotyping Service Product and Services
Table 68. Thermo Fisher Scientific Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Thermo Fisher Scientific Recent Developments/Updates
Table 70. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 71. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 72. Agilent Technologies Major Business
Table 73. Agilent Technologies Karyotyping Service Product and Services
Table 74. Agilent Technologies Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Agilent Technologies Recent Developments/Updates
Table 76. Agilent Technologies Competitive Strengths & Weaknesses
Table 77. Illumina Basic Information, Manufacturing Base and Competitors
Table 78. Illumina Major Business
Table 79. Illumina Karyotyping Service Product and Services
Table 80. Illumina Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Illumina Recent Developments/Updates
Table 82. Illumina Competitive Strengths & Weaknesses
Table 83. Bionano Genomics Basic Information, Manufacturing Base and Competitors
Table 84. Bionano Genomics Major Business
Table 85. Bionano Genomics Karyotyping Service Product and Services
Table 86. Bionano Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Bionano Genomics Recent Developments/Updates
Table 88. Bionano Genomics Competitive Strengths & Weaknesses
Table 89. Natera Basic Information, Manufacturing Base and Competitors
Table 90. Natera Major Business
Table 91. Natera Karyotyping Service Product and Services
Table 92. Natera Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Natera Recent Developments/Updates
Table 94. Natera Competitive Strengths & Weaknesses
Table 95. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 96. NeoGenomics Laboratories Major Business
Table 97. NeoGenomics Laboratories Karyotyping Service Product and Services
Table 98. NeoGenomics Laboratories Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. NeoGenomics Laboratories Recent Developments/Updates
Table 100. NeoGenomics Laboratories Competitive Strengths & Weaknesses
Table 101. Invitae Basic Information, Manufacturing Base and Competitors
Table 102. Invitae Major Business
Table 103. Invitae Karyotyping Service Product and Services
Table 104. Invitae Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Invitae Recent Developments/Updates
Table 106. Invitae Competitive Strengths & Weaknesses
Table 107. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 108. Fulgent Genetics Major Business
Table 109. Fulgent Genetics Karyotyping Service Product and Services
Table 110. Fulgent Genetics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Fulgent Genetics Recent Developments/Updates
Table 112. Fulgent Genetics Competitive Strengths & Weaknesses
Table 113. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 114. BGI Genomics Major Business
Table 115. BGI Genomics Karyotyping Service Product and Services
Table 116. BGI Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BGI Genomics Recent Developments/Updates
Table 118. BGI Genomics Competitive Strengths & Weaknesses
Table 119. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Berry Genomics Major Business
Table 121. Berry Genomics Karyotyping Service Product and Services
Table 122. Berry Genomics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Berry Genomics Recent Developments/Updates
Table 124. Berry Genomics Competitive Strengths & Weaknesses
Table 125. KingMed Diagnostics Basic Information, Manufacturing Base and Competitors
Table 126. KingMed Diagnostics Major Business
Table 127. KingMed Diagnostics Karyotyping Service Product and Services
Table 128. KingMed Diagnostics Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. KingMed Diagnostics Recent Developments/Updates
Table 130. KingMed Diagnostics Competitive Strengths & Weaknesses
Table 131. Daan Gene Basic Information, Manufacturing Base and Competitors
Table 132. Daan Gene Major Business
Table 133. Daan Gene Karyotyping Service Product and Services
Table 134. Daan Gene Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Daan Gene Recent Developments/Updates
Table 136. Daan Gene Competitive Strengths & Weaknesses
Table 137. Maccura Biotechnology Basic Information, Manufacturing Base and Competitors
Table 138. Maccura Biotechnology Major Business
Table 139. Maccura Biotechnology Karyotyping Service Product and Services
Table 140. Maccura Biotechnology Karyotyping Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Maccura Biotechnology Recent Developments/Updates
Table 142. Maccura Biotechnology Competitive Strengths & Weaknesses
Table 143. Global Key Players of Karyotyping Service Upstream (Raw Materials)
Table 144. Global Karyotyping Service Typical Customers
LIST OF FIGURES
Figure 1. Karyotyping Service Picture
Figure 2. World Karyotyping Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Karyotyping Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Karyotyping Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Karyotyping Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 13. Karyotyping Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Karyotyping Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Karyotyping Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Karyotyping Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Karyotyping Service Markets in 2025
Figure 27. United States VS China: Karyotyping Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Karyotyping Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Karyotyping Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Karyotyping Service Market Size Market Share by Type in 2025
Figure 31. G-Banding Karyotyping
Figure 32. Q-Banding Karyotyping
Figure 33. R-Banding Karyotyping
Figure 34. C-Banding Karyotyping
Figure 35. Spectral Karyotyping (SKY)
Figure 36. Multicolor FISH-based Karyotyping
Figure 37. World Karyotyping Service Market Size Market Share by Type (2021-2032)
Figure 38. World Karyotyping Service Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Figure 39. World Karyotyping Service Market Size Market Share by Sample in 2025
Figure 40. Peripheral Blood Karyotyping
Figure 41. Amniotic Fluid Karyotyping
Figure 42. Chorionic Villus Sample Karyotyping
Figure 43. Bone Marrow Karyotyping
Figure 44. Tumor Tissue Karyotyping
Figure 45. Cell Culture Karyotyping
Figure 46. World Karyotyping Service Market Size Market Share by Sample (2021-2032)
Figure 47. World Karyotyping Service Market Size by Resolution, (USD Million), 2021 & 2025 & 2032
Figure 48. World Karyotyping Service Market Size Market Share by Resolution in 2025
Figure 49. Low Resolution Karyotype Analysis (350–450 bands)
Figure 50. Medium Resolution Karyotype Analysis (450–550 bands)
Figure 51. High Resolution Karyotype Analysis (550–850+ bands)
Figure 52. World Karyotyping Service Market Size Market Share by Resolution (2021-2032)
Figure 53. World Karyotyping Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Karyotyping Service Market Size Market Share by Application in 2025
Figure 55. Hospitals and Medical Centers
Figure 56. Diagnostic Laboratories
Figure 57. Fertility Clinics
Figure 58. Biotechnology Companies
Figure 59. Pharmaceutical Companies
Figure 60. Academic and Research Institutions
Figure 61. World Karyotyping Service Market Size Market Share by Application (2021-2032)
Figure 62. Karyotyping Service Industrial Chain
Figure 63. Methodology
Figure 64. Research Process and Data Source
Figure 1. Karyotyping Service Picture
Figure 2. World Karyotyping Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Karyotyping Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Karyotyping Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Karyotyping Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Karyotyping Service Revenue (2021-2032) & (USD Million)
Figure 13. Karyotyping Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Karyotyping Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Karyotyping Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Karyotyping Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Karyotyping Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Karyotyping Service Markets in 2025
Figure 27. United States VS China: Karyotyping Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Karyotyping Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Karyotyping Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Karyotyping Service Market Size Market Share by Type in 2025
Figure 31. G-Banding Karyotyping
Figure 32. Q-Banding Karyotyping
Figure 33. R-Banding Karyotyping
Figure 34. C-Banding Karyotyping
Figure 35. Spectral Karyotyping (SKY)
Figure 36. Multicolor FISH-based Karyotyping
Figure 37. World Karyotyping Service Market Size Market Share by Type (2021-2032)
Figure 38. World Karyotyping Service Market Size by Sample, (USD Million), 2021 & 2025 & 2032
Figure 39. World Karyotyping Service Market Size Market Share by Sample in 2025
Figure 40. Peripheral Blood Karyotyping
Figure 41. Amniotic Fluid Karyotyping
Figure 42. Chorionic Villus Sample Karyotyping
Figure 43. Bone Marrow Karyotyping
Figure 44. Tumor Tissue Karyotyping
Figure 45. Cell Culture Karyotyping
Figure 46. World Karyotyping Service Market Size Market Share by Sample (2021-2032)
Figure 47. World Karyotyping Service Market Size by Resolution, (USD Million), 2021 & 2025 & 2032
Figure 48. World Karyotyping Service Market Size Market Share by Resolution in 2025
Figure 49. Low Resolution Karyotype Analysis (350–450 bands)
Figure 50. Medium Resolution Karyotype Analysis (450–550 bands)
Figure 51. High Resolution Karyotype Analysis (550–850+ bands)
Figure 52. World Karyotyping Service Market Size Market Share by Resolution (2021-2032)
Figure 53. World Karyotyping Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Karyotyping Service Market Size Market Share by Application in 2025
Figure 55. Hospitals and Medical Centers
Figure 56. Diagnostic Laboratories
Figure 57. Fertility Clinics
Figure 58. Biotechnology Companies
Figure 59. Pharmaceutical Companies
Figure 60. Academic and Research Institutions
Figure 61. World Karyotyping Service Market Size Market Share by Application (2021-2032)
Figure 62. Karyotyping Service Industrial Chain
Figure 63. Methodology
Figure 64. Research Process and Data Source
